Change search
ReferencesLink to record
Permanent link

Direct link
Thymidine selectively enhances growth suppressive effects of camptothecin/irinotecan in MSI+ cells and tumors containing a mutation of MRE11.
Show others and affiliations
2008 (English)In: Clin Cancer Res, ISSN 1078-0432, Vol. 14, no 17, 5476-83 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2008. Vol. 14, no 17, 5476-83 p.
Keyword [en]
Animals, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Camptothecin/*analogs & derivatives/*pharmacology/therapeutic use, Cell Line; Tumor, Colonic Neoplasms/*drug therapy/genetics/pathology, DNA-Binding Proteins/*genetics, Humans, Mice, Mice; Nude, Microsatellite Instability, Mutation, Thymidine/*pharmacology/therapeutic use, Tumor Stem Cell Assay, Xenograft Model Antitumor Assays
URN: urn:nbn:se:su:diva-16640ISI: 000259166000020PubMedID: 18765539OAI: diva2:183160
Available from: 2008-12-19 Created: 2008-12-19 Last updated: 2011-01-10Bibliographically approved

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Helleday, Thomas
By organisation
Department of Genetics, Microbiology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 19 hits
ReferencesLink to record
Permanent link

Direct link